702 related articles for article (PubMed ID: 19174797)
1. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
2. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
3. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
[TBL] [Abstract][Full Text] [Related]
4. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
[TBL] [Abstract][Full Text] [Related]
5. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
[TBL] [Abstract][Full Text] [Related]
6. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
7. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
8. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
9. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
10. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
Ringel Y; Williams RE; Kalilani L; Cook SF
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
[TBL] [Abstract][Full Text] [Related]
12. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
[TBL] [Abstract][Full Text] [Related]
14. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
15. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life.
Ansari R; Attari F; Razjouyan H; Etemadi A; Amjadi H; Merat S; Malekzadeh R
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):46-50. PubMed ID: 18090990
[TBL] [Abstract][Full Text] [Related]
16. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
[TBL] [Abstract][Full Text] [Related]
17. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
Kong WM; Gong J; Dong L; Xu JR
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
[TBL] [Abstract][Full Text] [Related]
18. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
Barbara G
Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiology of irritable bowel syndrome.
Schwetz I; Bradesi S; Mayer EA
Minerva Med; 2004 Oct; 95(5):419-26. PubMed ID: 15467517
[TBL] [Abstract][Full Text] [Related]
20. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
